PMC:7600245 / 87167-87950
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T410","span":{"begin":616,"end":624},"obj":"Disease"}],"attributes":[{"id":"A410","pred":"mondo_id","subj":"T410","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Supplementary Materials\nThe following are available online at https://www.mdpi.com/1999-4915/12/10/1092/s1, Figure S1: The chemical structure of tenofovir disoproxil and schematic representation of its metabolic bioactivation, Figure S2: The chemical structure of tenofovir alafenamide and schematic representation of its metabolic bioactivation, Figure S3: The chemical structure of AT-527 and schematic representation of its metabolic bioactivation, Figure S4: The chemical structure of danoprevir and maraviroc, Figure S5: The chemical structures of three natural products that are currently being tested against COVID-19, Figure S6: The chemical structures of various agents with potential antiviral activity attributed to various mechanisms.\nClick here for additional data file."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T892","span":{"begin":104,"end":106},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T893","span":{"begin":115,"end":117},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T894","span":{"begin":234,"end":236},"obj":"http://purl.obolibrary.org/obo/CLO_0008922"},{"id":"T895","span":{"begin":234,"end":236},"obj":"http://purl.obolibrary.org/obo/CLO_0050052"},{"id":"T896","span":{"begin":522,"end":524},"obj":"http://purl.obolibrary.org/obo/CLO_0008933"},{"id":"T897","span":{"begin":601,"end":607},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T898","span":{"begin":704,"end":712},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Supplementary Materials\nThe following are available online at https://www.mdpi.com/1999-4915/12/10/1092/s1, Figure S1: The chemical structure of tenofovir disoproxil and schematic representation of its metabolic bioactivation, Figure S2: The chemical structure of tenofovir alafenamide and schematic representation of its metabolic bioactivation, Figure S3: The chemical structure of AT-527 and schematic representation of its metabolic bioactivation, Figure S4: The chemical structure of danoprevir and maraviroc, Figure S5: The chemical structures of three natural products that are currently being tested against COVID-19, Figure S6: The chemical structures of various agents with potential antiviral activity attributed to various mechanisms.\nClick here for additional data file."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T11017","span":{"begin":145,"end":165},"obj":"Chemical"},{"id":"T17911","span":{"begin":145,"end":154},"obj":"Chemical"},{"id":"T18391","span":{"begin":234,"end":236},"obj":"Chemical"},{"id":"T48135","span":{"begin":264,"end":285},"obj":"Chemical"},{"id":"T98462","span":{"begin":264,"end":273},"obj":"Chemical"},{"id":"T84232","span":{"begin":354,"end":356},"obj":"Chemical"},{"id":"T37726","span":{"begin":459,"end":461},"obj":"Chemical"},{"id":"T36223","span":{"begin":504,"end":513},"obj":"Chemical"},{"id":"T5010","span":{"begin":522,"end":524},"obj":"Chemical"},{"id":"T71346","span":{"begin":694,"end":703},"obj":"Chemical"}],"attributes":[{"id":"A51308","pred":"chebi_id","subj":"T11017","obj":"http://purl.obolibrary.org/obo/CHEBI_63717"},{"id":"A14615","pred":"chebi_id","subj":"T17911","obj":"http://purl.obolibrary.org/obo/CHEBI_134504"},{"id":"A88949","pred":"chebi_id","subj":"T17911","obj":"http://purl.obolibrary.org/obo/CHEBI_63625"},{"id":"A83026","pred":"chebi_id","subj":"T17911","obj":"http://purl.obolibrary.org/obo/CHEBI_63716"},{"id":"A90093","pred":"chebi_id","subj":"T18391","obj":"http://purl.obolibrary.org/obo/CHEBI_29387"},{"id":"A61446","pred":"chebi_id","subj":"T48135","obj":"http://purl.obolibrary.org/obo/CHEBI_90926"},{"id":"A75156","pred":"chebi_id","subj":"T98462","obj":"http://purl.obolibrary.org/obo/CHEBI_134504"},{"id":"A70900","pred":"chebi_id","subj":"T98462","obj":"http://purl.obolibrary.org/obo/CHEBI_63625"},{"id":"A99478","pred":"chebi_id","subj":"T98462","obj":"http://purl.obolibrary.org/obo/CHEBI_63716"},{"id":"A90879","pred":"chebi_id","subj":"T84232","obj":"http://purl.obolibrary.org/obo/CHEBI_29388"},{"id":"A97647","pred":"chebi_id","subj":"T37726","obj":"http://purl.obolibrary.org/obo/CHEBI_29401"},{"id":"A33340","pred":"chebi_id","subj":"T36223","obj":"http://purl.obolibrary.org/obo/CHEBI_63608"},{"id":"A56199","pred":"chebi_id","subj":"T5010","obj":"http://purl.obolibrary.org/obo/CHEBI_29386"},{"id":"A88889","pred":"chebi_id","subj":"T71346","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"Supplementary Materials\nThe following are available online at https://www.mdpi.com/1999-4915/12/10/1092/s1, Figure S1: The chemical structure of tenofovir disoproxil and schematic representation of its metabolic bioactivation, Figure S2: The chemical structure of tenofovir alafenamide and schematic representation of its metabolic bioactivation, Figure S3: The chemical structure of AT-527 and schematic representation of its metabolic bioactivation, Figure S4: The chemical structure of danoprevir and maraviroc, Figure S5: The chemical structures of three natural products that are currently being tested against COVID-19, Figure S6: The chemical structures of various agents with potential antiviral activity attributed to various mechanisms.\nClick here for additional data file."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T677","span":{"begin":0,"end":23},"obj":"Sentence"},{"id":"T678","span":{"begin":24,"end":118},"obj":"Sentence"},{"id":"T679","span":{"begin":119,"end":237},"obj":"Sentence"},{"id":"T680","span":{"begin":238,"end":357},"obj":"Sentence"},{"id":"T681","span":{"begin":358,"end":462},"obj":"Sentence"},{"id":"T682","span":{"begin":463,"end":525},"obj":"Sentence"},{"id":"T683","span":{"begin":526,"end":636},"obj":"Sentence"},{"id":"T684","span":{"begin":637,"end":746},"obj":"Sentence"},{"id":"T685","span":{"begin":747,"end":783},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Supplementary Materials\nThe following are available online at https://www.mdpi.com/1999-4915/12/10/1092/s1, Figure S1: The chemical structure of tenofovir disoproxil and schematic representation of its metabolic bioactivation, Figure S2: The chemical structure of tenofovir alafenamide and schematic representation of its metabolic bioactivation, Figure S3: The chemical structure of AT-527 and schematic representation of its metabolic bioactivation, Figure S4: The chemical structure of danoprevir and maraviroc, Figure S5: The chemical structures of three natural products that are currently being tested against COVID-19, Figure S6: The chemical structures of various agents with potential antiviral activity attributed to various mechanisms.\nClick here for additional data file."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"2637","span":{"begin":616,"end":624},"obj":"Disease"}],"attributes":[{"id":"A2637","pred":"tao:has_database_id","subj":"2637","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Supplementary Materials\nThe following are available online at https://www.mdpi.com/1999-4915/12/10/1092/s1, Figure S1: The chemical structure of tenofovir disoproxil and schematic representation of its metabolic bioactivation, Figure S2: The chemical structure of tenofovir alafenamide and schematic representation of its metabolic bioactivation, Figure S3: The chemical structure of AT-527 and schematic representation of its metabolic bioactivation, Figure S4: The chemical structure of danoprevir and maraviroc, Figure S5: The chemical structures of three natural products that are currently being tested against COVID-19, Figure S6: The chemical structures of various agents with potential antiviral activity attributed to various mechanisms.\nClick here for additional data file."}